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Abstract
IMPORTANCE Few studies have investigated levels of mortality in patients with attention-deficit/
hyperactivity disorder (ADHD), and findings have been inconsistent and lacking information on
specific causes of deaths.
OBJECTIVE To investigate the association between ADHD and causes of death in Taiwan.
DESIGN, SETTING, ANDPARTICIPANTS A nationwide population-based cohort study was
conducted using a cross-national Taiwanese registry. The ADHD group comprised 275 980
individuals aged 4 to 44 years with a new diagnosis between January 1, 2000, and December 31,
2012. All individuals with ADHDwere compared with 1 931 860 sex- and age-matched controls
without ADHD.
EXPOSURES The association between ADHD andmortality was analyzed using a Cox regression
model that controlled for sex, age, residence, insurance premium, outpatient visits, congenital
anomaly, intellectual disability, depression disorder, autism, substance use disorder, conduct
disorder, and oppositional defiant disorder. The analysis of suicide, unintentional injury, homicide,
and natural-cause mortality was performed by a competing risk adjusted Cox regression controlling
for other causes of mortality and potential confounding factors.
MAINOUTCOMES ANDMEASURES Data onmortality from all causes, suicide, unintentional injury,
homicide, and natural causes collected from a national mortality database.
RESULTS There were 275 980 individuals with ADHD and 1 931 860 comparison individuals without
ADHD in this study. Sex and age at index datewerematched. Themean (SD) agewas 9.61 (5.74) years
for both groups. Most of the participants were male (209406 in the ADHD group; 1 465 842 in the
non-ADHD group; 75.88% for both groups). A total of 4321 participants from both cohorts died
during the follow-up period (15.1 million person-years), including 727 (0.26%) from the ADHD group
and 3594 (0.19%) from the non-ADHD group. Of those who died, 546 (75.1%) in the ADHD group
and 2852 (79.4%) in the non-ADHD group were male. After adjusting for potential confounders,
compared with the non-ADHD group, patients with ADHD showed higher overall mortality (adjusted
hazard ratio, 1.07; 95%CI, 1.00-1.17) and higher injury-causemortality from suicide (adjusted hazard
ratio, 2.09; 95%CI, 1.62-2.71), unintentional injury (adjusted hazard ratio, 1.30; 95%CI, 1.10-1.52), and
homicide (adjusted hazard ratio, 2.00; 95% CI, 1.09-3.68). No increased risk of natural-cause
mortality was observed after adjustment.
CONCLUSIONS ANDRELEVANCE In this study, ADHDwas associated with higher injury-cause
mortality, particularly that due to suicide, unintentional injury, and homicide. Although the risk of
(continued)
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Abstract (continued)
injury mortality was significantly higher in patients with ADHD than in the non-ADHD group, the
absolute risk of mortality was low.
JAMA Network Open. 2019;2(8):e198714. doi:10.1001/jamanetworkopen.2019.8714
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with an
estimated worldwide prevalence of 7.2% among children and adolescents.1 In 60% of individuals,
symptoms of ADHD persist into adulthood.2 Attention-deficit/hyperactivity disorder has been found
to be associated with a range of adverse outcomes, including worse academic achievement, other
mental disorders, substance use disorders, criminality, unemployment, and increased health system
costs and use.3 Associations between ADHD and adverse physical health–related outcomes,4 such
as diabetes5 and traumatic brain injury,6 have also been described.
Despite functional impairments and adverse health consequences associated with ADHD,
investigations of mortality associations are scant, although all suggest higher risk.7-9 For example,
Barbaresi et al7 reported a standardizedmortality ratio of 1.88 among patients with ADHD, although
this was not statistically significant (95%CI, 0.83-4.26; P = .13). The Danish population-based cohort
study by Dalsgaard et al8 described a 2-fold highermortality rate in individuals with ADHD compared
with thosewithout it (mortality rate ratio, 2.07; 95%CI, 1.70-2.50), and London and Landes9 showed
similar results, with an adjusted odds ratio of 1.78 (95% CI, 1.01-3.12). A 33-year follow up study10,11
of 207 boys with ADHD and 178 boys without ADHD and showed higher injury deaths among the
boys with ADHD (10 of 207 vs 1 of 178; P = .01). However, shortcomings of previous studies have
included insufficient number of deaths for cause-specific analysis,7-11 short follow-up periods,9 and
limited capacity to adjust for important potential confounders such as comorbid psychiatric
disorders.7,9
Understanding specific causes of mortality, including natural, unintentional injury, suicidal, or
other injury causes of deaths, may provide insight for further definite interventions to reduce the risk
of mortality in patients with ADHD. Hence, we designed this study to investigate and compare the
risks of both overall and cause-specific mortality after controlling for possible confounders in people
with or without ADHDwhowere identified using a large population-based data set.
Methods
Samples
The government of Taiwan initiated a nationwide health insurance program—the National Health
Insurance—onMarch 1, 1995. By December 2010, more than 23.07million people were enrolled in
the National Health Insurance system, yielding a coverage rate of 99.6% of residents in Taiwan. The
National Health Research Institute then created the National Health Insurance Research Database
from the National Health Insurance,12 deidentifying personal information and filing health care
receipts. In this nationwide cohort study, we extracted information from the National Health
Insurance Research Database onmedical use among individuals aged 4 to 44 years for whom an
ADHD diagnosis (International Classification of Diseases, Ninth Revision [ICD-9] code 314) was
recorded between January 1, 2000, and December 31, 2012. The age range of 4 to 44 years was
chosen because ADHDwas unlikely to be diagnosed outside this range. The date of the first ADHD
diagnosis was defined as the index date. The index date for participants in the comparison group was
assigned as the date of the first ADHD diagnosis of their matched counterparts with ADHD. Sex- and
age-matched comparison participants without a recorded diagnosis of ADHDwere also selected at a
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ratio of 1:7 (Figure 1). The nationwideMortality Register for 2000 to 2013 was provided by the
Department of Health, the Executive Yuan of Taiwan.
The institutional review board of the National Taiwan Normal University approved this study.
Written informed consent from study participants was not required because information from the
National Health Insurance Research Database and the Mortality Register is anonymized and
deidentified. This study followed the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guidelines.
StudyVariables
Themain outcomemeasure for our cohorts was all-cause mortality. Deaths due to suicide,
unintentional injury, homicide, and natural causes were also extracted as variables of interest.
Because suicide mortality statistics are often underestimated andmisclassified, suicide was defined
as having ICD-9 codes E950 to E959 (suicide) and E980 to E989 (injury undetermined whether
accidentally or purposely inflicted). Mortality due to unintentional injuries was defined as ICD-9
codes E800 to E949. Mortality by homicide was defined as ICD-9 codes E960 to E969. Mortality by
natural cause was defined as having causes other than suicide, unintentional injury, and homicide.
Demographic variables included age, sex, levels of income, and urbanization. The level of
income served as an indicator of economic status and was classified into 3 categories of monthly
income (given in New Taiwan dollars [NT$]): (1) less than NT$20000, (2) NT$20000 to NT$39999,
and (3) NT$40000 and higher (US$1 = NT$32.1 in 2010). Other covariates included the presence at
baseline of congenital anomaly (ICD-9 codes 740-759), intellectual disability (ICD-9 codes 317-319),
depressive disorder (ICD-9 codes 296.2, 296.3, 300.4, and 311), anxiety disorder (ICD-9 codes 300.0,
300.01, 300.02, 300.2, 300.21, 300.23, and 300.3), autism (ICD-9 code 299), substance use
disorder (ICD-9 codes, 303-304), and conduct disorder or oppositional defiant disorder (ICD-9 codes
312 and 313.81) before the index date. Outpatient visits within the year before the index date, which
served as an indicator ofmedical service use, was also a covariate andwas classified into 3 categories:
(1) 0 to 10, (2) 11 to 20, and (3) 21 times or more in a year.
Statistical Analysis
The risk of total and sex-specific mortality during the follow-up period was calculated through
survival analysis. The time function was calculated as the number of years from the index date to the
Figure 1. FlowchartofDataCollection inStudyofPatientsWithAttention-Deficit/HyperactivityDisorder (ADHD)
andMatchedControlsWithoutADHD
26 061 681 National Health Insurance Database,
1998-2013, Taiwan
25 730 345 No previous ADHD medical 
claim, 1997-2013
331 336 Outpatient or inpatient ADHD medical
claim (ICD-9: 314), 1998-2013
Excluded
17 742 ADHD first diagnosed in 1989-1999 for 
incident cases and ADHD first diagnosed 
in 2013 for at least 1 y of follow-up
22 238 ADHD first diagnosed at age <4 y
ADHD first diagnosed at age ≥45 y15 376
275 980 ADHD cohort: first ADHD diagnosis 
2000-2012, age 4-44 y
1 931 860 Non-ADHD cohort
Matching by sex, age (within 1 y), and index date 
(ADHD first diagnosis date)
ICD-9 indicates International Classification of Diseases,
Ninth Revision.
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date of death, withdrawal from the National Health Insurance program, or December 31, 2013 (the
end of follow-up).
All-causemortality was analyzed using a Cox regressionmodel. Other causes of mortality during
the follow-up period were considered as competing risk events for each of the specific-cause
mortality outcomes (ie, suicide, unintentional injury, homicide, and natural causes). Modified
log-rank test results were obtained using the Fine and Gray13 method, and adjusted cumulative
incidences were calculated. Competing risk-adjusted Cox regressionmodels13,14 were fitted to
estimate the association of ADHDwith specific-cause mortality after adjustment for covariates.
Competing risk-adjusted hazard ratios (HRs) with 95% confidence intervals were calculated. Because
the data fitted the proportional hazard assumption, Cox regression analysis was appropriate for the
analysis. For multivariate analyses, model 1 incorporated adjustment for demographic variables and
outpatient visits in the previous year, and model 2 incorporated further adjustments for baseline
comorbidities of congenital anomaly, intellectual disability, depressive disorder, anxiety disorder,
autism, substance use disorder, conduct disorder, or oppositional defiant disorder diagnosed before
the index date. Secondary analyses were performed after stratification by sex.
Data management was performed using SAS statistical software version 9.4 (SAS Institute).
Cumulative incidences and Coxmodel calculations in the competing risk analysis were performed
using the package cmprsk in R statistical software version 3.5.3 (R Project for Statistical
Computing).14 Two-tailed P < .05 (log-rank test) was considered statistically significant.
Results
Characteristics of ADHD and Control Groups
A total of 275 980 study participants with ADHD and 1 931 860 comparison participants without
ADHDwere identified. Table 1 depicts the demographic and clinical characteristics of the 2 groups.
The mean (SD) age was 9.61 (5.74) years for both groups. Most of the participants were male
(209406 in the ADHD group; 1 465 842 in the non-ADHD group; 75.88% for both groups). Sex and
age at index date werematched adequately. Comparing the 2 cohorts, those with ADHD had a higher
level of urbanization; lower levels of income; higher proportionswith congenital anomaly, intellectual
disability, depressive disorder, autism, substance use disorder, conduct disorder, and oppositional
defiant disorder; and higher numbers of outpatient visits. A total of 4321 participants from both
cohorts died during the follow-up period (15.1 million person-years), including 727 in the ADHD group
(0.26%) and 3594 in the non-ADHD group (0.19%). Of those who died, 75.1% (546) in the ADHD
group and 79.4% (2852) in the non-ADHD group weremale. The incidence rates of suicide,
unintentional injuries, and homicide for the ADHD group were 0.62 per 10000 person-years, 0.99
per 10000 person-years, and 0.07 per 10000 person-years, respectively. The incidence rates of
suicide, unintentional injuries, and homicide for the non-ADHD group were 0.19 per 10000 person-
years, 0.82 per 10000 person-years, and 0.04 per 10000 person-years, respectively. The ADHD
group had higher all-cause, suicide, unintentional injury, and homicide mortality than did the non-
ADHD group.
Unadjusted (Univariate) Analysis
Table 2 shows unadjusted comparisons of total and sex-specific mortality between the ADHD and
non-ADHD groups. The cumulative all-cause mortality rate in those with ADHD was significantly
higher than in the non-ADHD comparison group (Figure 2). The crude mortality rate for the ADHD
groupwas also significantly higher than that for the non-ADHD group (Table 2). The ADHD group had
significantly higher all-cause mortality (HR, 1.42; 95% CI, 1.31-1.54; P < .001), suicide mortality (HR,
3.19; 95% CI, 2.56-3.97; P < .001), unintentional injury mortality (HR, 1.21; 95% CI, 1.03-1.41; P = .01),
homicide mortality (HR, 2.04; 95% CI, 1.13-3.70; P = .007), and natural-cause mortality (HR, 1.30;
95% CI, 1.17-1.45; P < .001).
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Adjusted (Multivariate) Analysis
Compared with the unadjusted value (HR, 1.42; 95% CI, 1.31-1.54), the strength of association
between ADHD and all-cause mortality decreased slightly after model 1 adjustments (adjusted HR,
1.32; 95% CI, 1.22-1.43) andmore substantially after model 2 adjustments (adjusted HR, 1.07; 95% CI,
1.00-1.17) were made. After adjustments for competing risks and covariates in model 2, having the
diagnosis of ADHD remained associated with higher mortality from injury causes, including suicide
(adjusted HR, 2.09; 95%CI, 1.62-2.71), unintentional injury (adjusted HR, 1.30; 95%CI, 1.10-1.52), and
Table 1. Demographic and Clinical Characteristics of PatientsWith ADHD and Sex- and Age-Matched Controls
Without ADHD, Taiwan, 2000 to 2012a
Characteristic
No. (%)
P ValueGroup With ADHD Group Without ADHD
No. 275 980 1 931 860
Sex
Male 209 406 (75.88) 1 465 842 (75.88)
>.99
Female 66 574 (24.12) 466 018 (24.12)
Age at index date, y
4-11 222 967 (80.79) 1 560 769 (80.79)
>.9912-17 38 266 (13.87) 267 862 (13.87)
18-44 14 747 (5.34) 103 229 (5.34)
Level of urbanization
Rural 42 807 (15.51) 403 740 (20.90)
<.001
Urban 233 173 (84.49) 1 528 120 (79.10)
Level of income, NT$
<20 000b 84 743 (30.71) 578 681 (29.95)
<.00120 000-39 999 132 499 (48.01) 965 387 (49.97)
≥40 000 58 738 (21.28) 387 792 (20.07)
Congenital anomaly
Yes 4318 (1.56) 16 188 (0.84)
<.001
No 271 662 (98.44) 1 915 672 (99.16)
Intellectual disability
Yes 7417 (2.69) 5356 (0.28)
<.001
No 268 563 (97.31) 1 926 504 (99.72)
Depressive disorder
Yes 3335 (1.21) 1992 (0.10)
<.001
No 272 645 (98.79) 1 929 868 (99.9)
Anxiety disorder
Yes 271 490 (98.37) 1 927 564 (99.78)
<.001
No 4490 (1.63) 4296 (0.22)
Autism
Yes 5385 (1.95) 3277 (0.17)
<.001
No 270 595 (98.05) 1 928 583 (99.83)
Substance use disorder
Yes 2124 (0.77) 8834 (0.46)
<.001
No 273 856 (99.23) 1 923 026 (99.54)
Conduct disorder or oppositional defiant
disorder
Yes 682 (0.25) 306 (0.02)
<.001
No 275 298 (99.75) 1 931 554 (99.98)
Outpatient visits (times)c
0-10 72 983 (26.45) 761 888 (39.44)
<.00111-20 82 961 (30.06) 568 960 (29.45)
≥21 120 036 (43.49) 601 012 (31.11)
Abbreviation: ADHD, attention-deficit/hyperactivity
disorder.
a International Classification of Diseases, Ninth
Revision codes include the following: congenital
anomaly (740-759), intellectual disability (317-319),
depressive disorder (296.2, 296.3, 300.4, and 311),
anxiety disorders (300.0, 300.01, 300.02, 300.2,
300.21, 300.23, and 300.3), substance use disorder
(303-304), conduct disorder or oppositional defiant
disorder (312 and 313.81), suicide (950-959 and
980-989), unintentional injury (800-949),
homicide (960-969), and natural-causemortality
(all-causemortality excluded suicide, unintentional
injury, and homicide).
b 1 US$ = 32.1 NT$ (New Taiwan dollars) in 2010.
c Past 1 year before the index date.
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Table 2. Comparative Univariate Analysis of Mortality Between PatientsWith ADHD and a Group of ControlsWithout ADHD, Taiwan, 2000 to 2012
Outcome or Subgroup
Group With ADHD Group Without ADHD
Estimate,
HR (95% CI)a P Value
Deaths,
No.
Person-Years,
No.
Rate,
Deaths/
10 000
Person-
Years
Deaths,
No.
Person-Years,
No.
Rate,
Deaths/
10 000
Person-
Years
All cause
Total 727 189 2521 3.84 3594 13 254 591 2.71 1.42 (1.31-1.54) <.001
Male 546 1 443 000 3.78 2852 10 105 209 2.82 1.34 (1.22-1.47) <.001
Female 181 449 521 4.03 742 3 149 381 2.36 1.71 (1.45-2.01) <.001
Suicide
Total 117 1 892 521 0.62 257 13 254 591 0.19 3.19 (2.56-3.97) <.001
Male 76 1 443 000 0.53 186 10 105 209 0.18 2.86 (2.19-3.74) <.001
Female 41 449 521 0.91 71 3 149 381 0.23 4.04 (2.75-5.94) <.001
Unintentional injury
Total 188 1 892 521 0.99 1090 13 254 591 0.82 1.21 (1.03-1.41) .01
Male 163 1 443 000 1.13 968 10 105 209 0.96 1.18 (1.01-1.39) .03
Female 25 449 521 0.56 122 3 149 381 0.39 1.44 (0.93-2.21) .15
Homicide
Total 14 1 892 521 0.07 48 13 254 591 0.04 2.04 (1.13-3.70) .007
Male 11 1 443 000 0.08 41 10 105 209 0.04 1.88 (1.01-3.65) .02
Female 3 449 521 0.07 7 3 149 381 0.02 3.00 (0.78-11.61) .25
Natural cause
Total 408 1 892 521 2.17 2199 13 254 591 1.67 1.30 (1.17-1.45) <.001
Male 295 1 443 000 2.07 1656 10 105 209 1.65 1.25 (1.11-1.42) <.001
Female 113 449 521 2.51 543 3 149 381 1.72 1.46 (1.19-1.79) <.001
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; HR, hazard ratio.
a All-causemortality was analyzed by the log-rank test; specific-causemortality was
analyzed by themodified log-rank test using the Fine and Gray13 method.
Figure 2. Comparison of All-Cause CumulativeMortality Between PatientsWith
Attention-Deficit/Hyperactivity Disorder (ADHD) and the Non-ADHDGroup, Taiwan, 2000 to 2012
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homicide (adjusted HR, 2.00; 95% CI, 1.09-3.68). However, no significant association was found
between ADHD andmortality from natural causes after full adjustment (Table 3).
Discussion
In what we believe to be the largest sample evaluated to date, we investigated associations of ADHD
with both all-cause and cause-specific mortality, incorporating adjustments for multiple potential
confounding factors. Our overarching finding was that injury rather than natural-cause mortality was
higher in individuals with ADHD than in a comparison cohort. Although unintentional injuries
accounted for the highest number of deaths from injury causes, the highest excess risk of mortality
in the ADHD group was for suicide.
Our finding of an association between ADHD and all-cause mortality is consistent with those
reported by previous studies.8,9 However, another study by Barbaresi et al7 reported no increased
risk ofmortality among patients with ADHD, with standardizedmortality ratios of 1.88 (95%CI, 0.83-
4.26; P = .13).
Our finding for higher injury mortality was also similar to that reported by Dalsgaard et al.8 The
longest follow-up study10 also showed higher rates of injury deaths among boys with ADHD than in a
comparison group (10 of 207 vs 1 of 178; P = .01), but the low sample size cannot allow for further
multiple analysis to control confounders or detect the separate effect of different types of injuries.
On investigating cause-specific mortality further, we found that the ADHD group had higher suicide,
unintentional injury, and homicidemortality rates than the comparison group. Previous studies have
failed to identify a statistically significant risk of unintentional deaths in ADHD,7,9 although they have
been limited by sample size. For example, the standardized mortality ratio was 1.70 (95% CI, 0.49-
5.97) in the study by Barbaresi et al,7 with only 3 deaths due to unintentional injuries in their ADHD
cohort. That study7 also showed significantly increased suicide deaths in patients with ADHD, but the
authors were not able to adjust for confounding factors such as comorbidity. Some studies8,9 have
shown that demographic characteristics (eg, age and sex) and psychiatric comorbidities, such as
Table 3. ComparativeMultivariate Analysis of Mortality Between PatientsWith Attention-Deficit/Hyperactivity
Disorder and a Control GroupWithout Attention-Deficit/Hyperactivity Disorder, Taiwan, 2000 to 2012
Outcome or Subgroup
Adjusted Model 1a Adjusted Model 2b
HR (95% CI) P Value HR (95% CI) P Value
All-cause
Total 1.32 (1.22-1.43) <.001 1.07 (1.00-1.17) .04
Male 1.26 (1.15-1.39) <.001 1.04 (0.94-1.14) .47
Female 1.52 (1.28-1.79) <.001 1.24 (1.04-1.48) .02
Suicidec
Total 2.71 (2.16-3.40) <.001 2.09 (1.62-2.71) <.001
Male 2.48 (1.88-3.28) <.001 2.06 (1.51-2.81) <.001
Female 3.18 (2.13-4.75) <.001 2.27 (1.44-3.59) <.001
Unintentional injuryc
Total 1.32 (1.12-1.54) .001 1.30 (1.10-1.52) .002
Male 1.29 (1.09-1.53) .003 1.28 (1.08-1.52) .005
Female 1.44 (0.92-2.26) .11 1.34 (0.83-2.18) .23
Homicidec
Total 2.10 (1.14-3.84) .02 2.00 (1.09-3.68) .03
Male 1.93 (0.98-3.79) .06 1.80 (0.92-3.55) .09
Female 3.06 (0.77-12.17 .11 3.06 (0.72-13.11) .13
Natural causec
Total 1.14 (1.02-1.27) .02 0.91 (0.80-1.15) .18
Male 1.09 (0.96-1.24) .17 0.83 (0.72-1.15) .17
Female 1.28 (1.04-1.58) .02 1.03 (0.82-1.30) .81
Abbreviation: HR, hazard ratio.
a Model 1: matched design by sex and age; adjusted by
residence, level of income, and outpatient visits past
1 year before the index date.
b Model 2: adjusted bymodel 1 and the presence of
congenital anomaly (International Classification of
Diseases, Ninth Revision codes 740-759), intellectual
disability (codes 317-319), depressive disorder (codes
296.2, 296.3, 300.4, and 311), anxiety disorder
(codes 300.0, 300.01, 300.02, 300.2, 300.21,
300.23, and 300.3), autism (code 299), substance
use disorder (codes 303-304), and conduct disorder
or oppositional defiant disorder (codes 312 and
313.81), which were diagnosed before the index date;
and suicide (codes 950-959 and 980-989),
unintentional injury (codes 800-949), homicide
(codes 960-969), and natural-cause mortality (all-
cause mortality excluded suicide, unintentional
injury, and homicide).
c Adjusted by other-causemortality through
competing risk-adjusted Cox regression.
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oppositional defiant disorder, conduct disorder, and substance use disorder, partially account for the
risk of death in individuals with ADHD. In our study, after full adjustment for sociodemographic
variables and comorbid psychiatric diagnoses, associations with natural-cause mortality were
attenuated to near-null values, but increased risk for suicide or unintentional injury deaths held even
when we controlled for comorbidities such as depression.
Underlying mechanisms associated with increased injury deaths in patients with ADHD, and the
possiblemitigating effects of treatment, warrant further investigation. Behaviors such as inattention,
hyperactivity, and impulsivity may increase the risk of unintentional injuries,15 and unintentional
injuries might result from an underestimation of the consequences of risk-taking behaviors. Previous
studies have also described increased traffic unintentional injuries in children with ADHD and other
mental disorders,8,16,17 and working memory impairment and impulsivity in ADHD could potentially
be responsible.18,19 Medication use has been reported to have the potential to reduce such risks.20
On the other hand, poor quality of life, lack of social support, and emotional dysregulation in children
with ADHDwere shown andmay also be associated with increased risk of suicidal behaviors.21
Potential sex differences were noted in our study, in that female patients with ADHD had
significantly increased all-causemortality risk in fully adjustedmodels, which was not present in male
patients with ADHD. This finding is consistent with those of a Danish study8 that reported higher
mortality risk in girls and women than in boys andmen. Referral bias might be a reason because
female patients with ADHD have been found to be referred for further evaluation less often than
male patients.22 Therefore, womenwho receive a medical referral and receive a diagnosis of ADHD
may present with much more severe behavioral symptoms and problems, thus accounting for
greater mortality risk. In addition, girls with ADHD have been reported to receive less treatment with
medication than boys, whichmay also contribute to their higher mortality risk.8,23 We found that
men with ADHDwere at a slightly increased risk of unintentional injury-related death compared with
menwithout ADHD, a male predominance that was also previously reported for unintentional
injury.24,25 However, other studies have not found sex differences in the risk of unintentional injury-
relatedmortality in patients with ADHD.20,26
Although the risk of suicide-relatedmortality was significantly higher in patients with ADHD
than in those without ADHD in our study, the absolute risk of mortality was low and suicide deaths
were rare (n = 117), with natural-cause deaths (n = 408) and unintentional injury deaths (n = 188)
accounting for a substantially higher number of deaths than suicide in the ADHD cohort. One
previous study8 also reported unintentional injuries to be the most common cause of death in this
patient group; however, of 107 deaths, information on cause was available for only 79 cases.
Findings from our study emphasize the importance of clinicians prioritizing the prevention of
risk factors for injury-caused premature deaths in patients with ADHD, rather than compounding the
stigma associated frequently with ADHD.27 Several studies have supported the evidence that ADHD
medication can effectively reduce the risk of physical injury,28 fracture,24 traffic crashes,20 brain
injury,29,30 and suicide.31 However, further research is still needed to estimate the potential effect of
medication on injurymortality, including earlier identification and treatment initialization. Teaching
emotional regulation, providing safety tips, educating on protective gear, and environmental
modificationmay also be helpful.21
Strengths and Limitations
To our knowledge, this is the first study using a national database to investigate associations between
ADHD and different causes of mortality after controlling for associated comorbidities. The
population-based cohort design diminished the likelihood of selection bias, beyond issues of access
to diagnosis discussed later, and its prospective nature reduced the risk of reverse causality. Wewere
also able to incorporate adjustment for a range of potential confounders. Notwithstanding, several
limitations should be borne in mind when drawing inferences from our findings. First, the ADHD
cohort was defined from routine health care data bymedical diagnosis rather than by structured
research-quality clinical interviews; furthermore, it is important to bear in mind that many patients
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with ADHDwill not receive a clinical diagnosis and our findings cannot be assumed to generalize to
those with undiagnosed disorder. Second, our study used observational data from the population in
Taiwan, and its generalizability to other international settings cannot be assumed. Third, we were
not able to consider and analyze the effects of ADHDmedications or other potential contributing
factors, such as family history and psychosocial stress.32 Some covariates adjusted for in our analyses
would have provided incomplete estimation of underlying parameters of interest (eg, undiagnosed
comorbidity not captured in health care records or occurring before the index date and limited
measurements of socioeconomic status). For example, ADHD onset was measured by first recorded
diagnosis, and the prediagnosis impact of ADHD has to be assumed; in addition, controlling for the
baseline covariate of depressionmight be biasing downward the effect of ADHD if depression served
as amediator of ADHD to suicide. Future exploration of the possible effects of ADHD treatments and
consideration of other confounders is required. Fourth, although the present study provided support
that the population with ADHD is at risk for higher mortality due to injury causes, it did not reveal
what might drive that risk. Further studies are warranted to explore the underlying mechanism.
Conclusions
This study found that ADHDwas associated with higher mortality, particularly increased risk of
mortality from injury causes, compared with mortality in a control group without ADHD. The highest
excess risk ofmortality in the ADHD groupwas for suicide, even after adjusting for the comorbidities
such as depression. The natural-cause mortality was attenuated to near-null values after adjustment
for sociodemographic variables and comorbid psychiatric diagnoses. It is imperative to explore the
underlying mechanisms of injury deaths in patients with ADHD to help develop effective
preventionmethods.
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